a public good project by the
Synthesis
Company
of California

© 2026

Subhani M. Okarvi | doi.page

0 works0 citations0 h-index

Subhani M. Okarvi

King Faisal Specialist Hospital & Research Centre(SA)

Publications by Year

Research Areas

Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Peptidase Inhibition and Analysis, Monoclonal and Polyclonal Antibodies Research, Neuroendocrine Tumor Research Advances

Most-Cited Works

→ Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer(2012)325 cited
→ Peptide‐based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases(2004)240 cited
→ Recent progress in fluorine-18 labelled peptide radiopharmaceuticals(2001)203 cited
→ Peptide-based radiopharmaceuticals and cytotoxic conjugates: Potential tools against cancer(2007)142 cited
→ Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals(1999)69 cited
→ Preparation and In Vitro and In Vivo Evaluation of Technetium- 99m -Labeled Folate and Methotrexate Conjugates as Tumor Imaging Agents(2006)49 cited

→ Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors(2010)

38 cited

→ Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas(2019)36 cited

→ Recent developments of prostate-specific membrane antigen (PSMA)-specific radiopharmaceuticals for precise imaging and therapy of prostate cancer: an overview(2019)35 cited

→ Rapid synthesis and in vitro and in vivo evaluation of folic acid derivatives labeled with fluorine-18 for PET imaging of folate receptor-positive tumors(2011)31 cited